معرفی
Dr. Abd El Kareem Azab is an Associate Professor of Biomedical Engineering at the University of Texas Southwestern Medical Center. He is a Rising Star CPRIT Scholar of Cancer Research and a Senior Member of The National Academy of Inventors. His research lab conducts multidisciplinary translational research focusing on cancer therapy, with emphasis on drug resistance, tumor microenvironment, immunotherapy, and advanced drug delivery systems.
- Pharmacy Studies – Hebrew University of Jerusalem
- M.Sc. in Medicinal Chemistry – Hebrew University of Jerusalem
- Ph.D. in Pharmaceutical Sciences – Hebrew University of Jerusalem
- Postdoctoral Training in Cancer Biology and Immunology – Dana-Farber Cancer Institute, Harvard University
Dr. Azab's research centers on translating laboratory discoveries into clinical applications. His work spans cancer biology, immunology, pharmaceutical sciences, and biomedical engineering. Key interests include overcoming tumor microenvironment-induced drug resistance, developing nanoparticle-based cancer theranostics, engineering biodegradable implants for localized therapy, and creating 3D tissue-engineered models for personalized cancer treatment.
Analysis of his recent publications reveals a strong trend toward immunotherapy, targeted drug delivery, and microenvironment modulation. His work frequently involves nanoparticle platforms, T-cell engagers, CD47 and CXCR4 targeting, and ex vivo models for therapy prediction. There is a clear translational arc from basic mechanisms to clinical applications, including ongoing trials.
- Rising Star CPRIT Scholar of Cancer Research
- Senior Member, National Academy of Inventors
Dr. Azab has founded four startup companies—Cellatrix LLC, Targeted Therapeutics LLC, OncInsights LLC, and CovACE Nanotechnology LLC—demonstrating a strong commitment to entrepreneurial translation. He has advised numerous graduate students and postdoctoral researchers, many of whom are co-authors on his publications. His lab receives significant grant support, particularly in cancer therapeutics and translational research. The Azab Lab operates as a multicultural, collaborative team focused on beating cancer through innovation.
The Azab Lab utilizes advanced technologies including 3D tissue-engineered bone marrow models, lipid and polymeric nanoparticles, drug-eluting implants, and boron neutron capture therapy agents. The lab fosters interdisciplinary collaboration and emphasizes bench-to-bedside translation through clinical trials and commercialization.
حوزههای پژوهشی
